AI | pharmaphorum

AI

Oncology

Interview at ESMO 2025 with EVERSANA's Barry Vucsko

ESMO25: Acceleration, accessibility, and accuracy, with Barr...

At ESMO25, pharmaphorum spoke with Barry Vucsko, Senior VP of Strategic Development, Agency Services, for the EVERSANA Oncology Centre of Excellence.

Digital

AI could save the NHS, but risks sharing private patient dat...

It’s becoming increasingly evident that simply anonymising and de-identifying sensitive data is no panacea for big tech’s data privacy problem.

Digital

pharmaphorum podcast Episode 208a, Dr Jay Anders

Improving ROI on AI investments and data quality, with Dr Ja...

Dr Jay Anders, chief medical officer for Medicomp Systems, discusses why he believes that the only way to solve AI ROI issues is to solve data quality

R&D

From pilots to patients: Why the UK must rethink NHS innovat...

At PharmaTech Integrates in Glasgow, speakers from government, academia, the NHS, and pharma sought to define the sector’s path forward.

Digital

12 Questions with Felix Faber

Mindpeak's Felix Faber is an award-winning entrepreneur and computer scientist with a track record of founding companies.

Digital

The right AI for the right job, with Iya Khalil

In a post-BIO virtual interview, Jonah Comstock speaks with Iya Khalil, VP and head of data, AI, and genome sciences at Merck & Co (MSD in Europe).

ESMO25: Acceleration, accessibility, and accuracy, with Barr...

AI could save the NHS, but risks sharing private patient dat...

Improving ROI on AI investments and data quality, with Dr Ja...

From pilots to patients: Why the UK must rethink NHS innovat...

12 Questions with Felix Faber

The right AI for the right job, with Iya Khalil

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

AI

Editor's Picks